Vaccinex, Inc. (VCNX)
NASDAQ: VCNX · IEX Real-Time Price · USD
7.50
0.00 (0.00%)
At close: Mar 28, 2024, 1:30 PM
8.39
+0.89 (11.87%)
After-hours: Mar 28, 2024, 6:51 PM EDT

Vaccinex Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Cash & Equivalents
6.398.5910.62.785.624.181.66
Short-Term Investments
000014.1100
Cash & Cash Equivalents
6.398.5910.62.7819.724.181.66
Cash Growth
-25.59%-18.94%281.70%-85.93%371.87%151.66%-
Receivables
0.1800.160.90.640.120.1
Other Current Assets
0.910.820.530.341.060.680.35
Total Current Assets
7.489.4111.294.0121.424.972.11
Property, Plant & Equipment
0.50.440.420.590.60.60.73
Total Long-Term Assets
0.50.440.420.590.60.60.73
Total Assets
7.989.8411.74.622.035.582.84
Accounts Payable
1.521.063.173.212.321.912.46
Deferred Revenue
000000.30
Current Debt
0.240.228.070000
Other Current Liabilities
0.780.981.943.674.361.961.98
Total Current Liabilities
2.542.2613.186.886.694.174.44
Long-Term Debt
0.250.181.13002.811.04
Other Long-Term Liabilities
000000.370.69
Total Long-Term Liabilities
0.250.181.13003.181.73
Total Liabilities
2.782.4314.316.886.697.356.17
Total Debt
0.490.399.21002.811.04
Debt Growth
24.36%-95.76%---171.26%-
Retained Earnings
-319.68-299.86-277.48-248.63-216.77-187.25-168.53
Shareholders' Equity
5.197.41-26.58-26.24-8.62-125.45-107.07
Net Cash / Debt
5.918.21.392.7819.721.370.62
Net Cash / Debt Growth
-27.97%490.71%-50.00%-85.93%1342.87%119.07%-
Net Cash Per Share
29.2359.6815.5245.26792.96260.53126.21
Working Capital
4.947.15-1.89-2.8714.740.81-2.33
Book Value Per Share
25.7053.95-297.06-427.75-346.58-23908.02-21657.60
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).